2/26/17. Medical Marijuana: Current Uses & Controversies. Learning Objectives. History of medical Cannabis

Size: px
Start display at page:

Download "2/26/17. Medical Marijuana: Current Uses & Controversies. Learning Objectives. History of medical Cannabis"

Transcription

1 Medical Marijuana: Current Uses & Controversies Joseph Rosales, MD Hematology & Medical Oncology May 18, Learning Objectives History of medical cannabis History of medical Cannabis 6000 BCE Cannabis seeds as food in Ancient China Basic science/chemistry 4000 BCE Hemp used for textiles Approved medical uses Controversy/Legalization BCE Egyptians use marijuana to treat sore eyes BCE Indians use marijuana for insomnia, headaches, GI complaints and pain 4 1

2 History of medical Cannabis Herodotus ( BCE) Pliny the Elder (77 AD) Dioscorides (40-90 AD) Claudius Galen de Alimentorum Facultatibus Hemp cakes, if eaten in moderation, produce a feeling of wellbeing, but taken in excess they lead to intoxication, dehydration and impotence 5 6 WB O Shaughnessy - Born in Limerick, Ireland in Studied medicine at University of Edinburgh - Helped treat cholera 1829 by using IV fluids and electrolyte repletion - Moved to India 1833 Cannabis indica is probably the most satisfactory remedy for migraines. - Sir William Osler, MD - Bengal Dispensatory and Bengal Pharmacopeia - Introduced medical marijuana to Europe 7 8 2

3 Basic Science & Chemistry of Marijuana 9 10 Indica Sativa Cannabinoids Δ9-THC Psychotropic Analgesic Appetite Stimulant Anxiety & Paranoia CBD Non-psychoactive Calming Anti-inflammatory

4 Brain Muscle GI Tract Pancreas Liver Adipose Tissue T- Cells B-Cels Monocytes Tonsils Spleen

5 17 18 Smoking Approved Medical Uses Vaporization Oral ingestion Oral-mucosal Rectal

6 21 22 Approved uses for Cannabis in WA MAINE Epilepsy/seizure disorders Glaucoma Multiple Sclerosis Muscle Spasticity Nausea/Vomiting from AIDS/Cancer ILLINOIS Cancer Glaucoma HIV/AIDS Hepatitis C ALS Crohn Disease Agitation due to Alzheimer s Disease Muscular Dystrophy Severe Fibromyalgia Tarlov Cysts Hydromyelia/Syringomyelia Rheumatoid Arthritis Fibrous Dysplasia Multiple Sclerosis Arnold-Chiari Malformation Parkinson s Disease Tourette s Syndrome Myoclonus/Dystonia RSD/CRPS Neurofibromatosis 23 SYMPTOMS Chronic Pain/Spasticity Nausea/vomiting Anorexia/Weight Loss/Muscle Wasting DISEASES Cancer HIV/AIDS Multiple Sclerosis Glaucoma Crohn s Disease Hepatitis C Chronic Renal Failure on Hemodialysis Post-Traumatic Stress Disorder 6

7 Chronic and severe pain From: Cannabinoids for Medical Use: A Systematic Review and Meta-analysis 28 studies, n= nabiximols, 4 smoked THC, 5 nabilone, 3 THC oromucosal spray, 2 dronabinol, 1 oral THC Placebo controlled 3 cancer pain, 3 diabetic neuropathy, 2 fibromyalgia, 2 HIV-associated neuropathy, MS, RA, musculoskeletal RESULTS: Average number of patients who report >30% reduction in pain was greater with cannabinoids than placebo (OR 1.41, CI ) JAMA. 2015;313(24): doi: /jama Figure Legend: Improvement in PainOdds indicate 30% or greater improvement in pain with cannabinoid compared with placebo, stratified according to cannabinoid. The square data markers indicate odds ratios (ORs) from primary studies, with sizes reflecting the statistical weight of the study using random-effects meta-analysis. The horizontal lines indicate 95% CIs. The blue diamond data markers represent the subtotal and overall OR and 95% CI. The vertical dashed line shows the summary effect estimate, the dotted shows the line of no effect (OR = 1). Copyright 2015 American Medical Association. 25 Date of download: 7/23/2015 All rights reserved. Nausea/vomiting 28 studies, n= Nabilone, 3 dronabinol,1 nabiximol, 4 levonantradol, 6 THC 8 vs placebo, 20 vs active comparator (prochlorperazine, chlorpromazine, metoclopramide, ondansetron) RESULTS: Higher incidence of complete response with cannabinoids than placebo RESULTS: Similar efficacy to prochlorperzine, chlorpromazine, metoclopramide

8 Spasticity (MS or Paraplegia) From: Cannabinoids for Medical Use: A Systematic Review and Meta-analysis 14 studies, n= nabiximols, 3 dronabinol, 1 nabilone, 4 THC/CBD, 1 smoked THC All placebo-controlled; none with comparator RESULTS: Non-statistically significant improvement in spasticity in favor of cannabinoids Ashworth scale for spasticity improvement greater for cannabinoids vs placebo JAMA. 2015;313(24): doi: /jama Figure Legend: Change in Ashworth Score for Cannabinoid Compared With Placebo, Stratified According to CannabinoidThe square data markers indicate mean differences from primary studies, with sizes reflecting the statistical weight of the study using random-effects metaanalysis. The horizontal line indicate, 95% CIs. The blue diamond data markers represent the subtotal and overall weighted mean difference and 95% CI. The vertical dashed line shows the summary effect estimate, the solid vertical line shows the line of no effect (mean difference = 0). Copyright 2015 American Medical Association. 29 Date of download: 7/23/2015 All rights reserved. Appetite Glaucoma 4 studies, n=255 (HIV/AIDS) Dronabinol 3 with placebo, 1 with megestrol acetate Dronabinol showed trend towards increased appetite/weight gain vs placebo Megestrol showed greater weight gain than dronabinol Clinical trial in Anorexia Nervosa (Andries, et. al, 2014) Dronabinol 5mg/day resulted in 0.73kg increase in 4 weeks Historical/Observational Decreased intraocular pressure Duration: 4 hours 1 study, n=6 TCH, CBD (oral & mucosal) No difference in IOP Concerns: THC can lower BP/IOP

9 Crohn s Disease Post-Traumatic Stress Disorder N=21, refractory to - steroids - immune therapy - anti-tnf Placebo High-THC Cannabis Cigarettes Partial Response 4/10 40% 10/11 90% Complete Response 1/10 10% 5/11 45% Naftali, et. al., J. Clin. Gastro. Hepatol., patients weaned from steroid dependency 33 No randomized clinical trial Observational study of 80 patients shows improvement of PTSD symptoms with marijuana (Greer, 2009) Observational study of 2276 patients shows higher symptom rates in marijuana users (Wilkinson, et. al, 2014) Study shows CBD decreases anxiety in those with and without anxiety disorder (Crippa, et. al., 2009) CBD shown to decrease symptoms of social anxiety disorder (Bergamaschi, et. al., 2011) 34 Unallowed Diagnoses (in WA) Tourette s Syndrome ADHD/OCD Alzheimer s Disease Neuropathic Pain Mania/Depression

10 Acute Cannabis Poisoning Cannabinoid Hyperemesis Syndrome Natural Cannabis Anxiety/Psychosis Sedation Hallucination Memory deficits Acute psychosis Scleral Injection Tachycardia/Tachypnea Hypertension Tremors Synthetic Cannabinoids Hypokalemia Nausea/Vomiting Seizures Agitation Violent Behavior Coma 37 First mentioned patients with cyclic nausea/vomiting associated with THC - 7/9 improved with cessation of THC Several case studies over the last 10 years case study case series case study 38 Legal Status Schedule I Marijuana (cannabis) Heroin LSD Ecstasy Methoqualone Peyote Schedule II Cocaine Methamphetamine Opioids Adderall/Ritalin Dexedrine

11 41 42 The prosecution of significant traffickers of illegal drugs, including marijuana continue to be a core priority in the Department s efforts against narcotics and dangerous drugs. prosecution of individuals with cancer or other serious illnesses who use marijuana as part of a recommended treatment regimen or those caregivers in clear and unambiguous compliance with existing state law who provide such individuals with marijuana, is unlikely to be an efficient use of limited federal resources

12 The Ogden memo was never meant to shield such activities from federal enforcement and prosecution, even when those activities purport to comply with state law. Persons who are in the business of cultivating, selling or distributing marijuana, and those who knowingly facilitate such activities, are in violation of the controlled substances act. PROHIBITS: Sales to minors Sales to criminal enterprises, gangs, cartels Diversion to other states where marijuana is illegal Used as a cover for trafficking other illegal drugs Violence/firearms in cultivation of marijuana Drugged driving Marijuana growth on public/federal property If state enforcement efforts are not sufficiently robust to protect against the harms set forth the federal government may seek to challenge the regulatory structure itself in addition to continuing to bring individual enforcement actions, including criminal prosecution, focused on those harms

13 49 50 Practical considerations Establish patient/physician relationship Identify indication for medical marijuana We (the DEA) support research on marijuana and its components that complies with applicable laws and regulations to advance our understanding about the health risks and potential therapeutic benefits of medications using marijuana or its components or derivatives. Document attempts at other medications Fill out certificate for medical marijuana 51 Document patient s use and results 52 13

14 Washington State DOH SB 5052 Defines medical vs recreational marijuana Medical Endorsement Consultant Certificate Patient Authorization Database Larger amounts No sales tax Arrest protection for patient/surrogate Review Cannabis contains >70 cannabinoids, the most abundant of which are THC and CBD, which activate receptors along the endocannabinoid pathway, resulting in its varied effects. Cannabis is currently a schedule I drug according to the US Government, which means it has a high potential for abuse and no acceptable medical use. Studies have shown benefit of cannabis in several specific indications, including nausea/vomiting, chronic pain, spasticity/seizures and anorexia Review Medical cannabis is legal in 24 states and Guam and Washington DC, though indications vary. Difficulties lie in standardization of THC/CBD content, with much available product being inaccurately labeled. Physician recommendations for cannabis must follow strict guidelines for documentation, with a standardized authorization form. Governmental policy appears headed in the direction of leniency with regards to cannabis use

15 Thank You

Medical Marijuana: Hype versus Evidence

Medical Marijuana: Hype versus Evidence Medical Marijuana: Hype versus Evidence Monica Malec, MD The University of Chicago, Department of Medicine Section of Geriatrics and Palliative Medicine Objectives Understand the requirements for physician

More information

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests

More information

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers

More information

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

The Return of Medicinal Cannabis

The Return of Medicinal Cannabis The Return of Medicinal Cannabis George Kolodner, M.D. DLFAPA FASAM Chief Clinical Officer Clinical Professor of Psychiatry Georgetown University School of Medicine University of Maryland School of Medicine

More information

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure. Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure

More information

Act 16 and Medical Cannabis in Pennsylvania

Act 16 and Medical Cannabis in Pennsylvania Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health

More information

CANNABIS FOR THE RHEUMATOLOGIST

CANNABIS FOR THE RHEUMATOLOGIST CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology

More information

CBD and Your Health.

CBD and Your Health. CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear

More information

Medical Marijuana Consent Form

Medical Marijuana Consent Form Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal

More information

Doc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds

Doc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds Doc, will you sign my medical marijuana card? Daniel W. Bowles, MD Fellow in Hematology/Medical Oncology General Internal Medicine i Grand Rounds September 21, 2010 Disclosures Skeptical about marijuana

More information

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015 Medical Marijuana Kent W. Peterson, MD, FACOEM Occupational Health Strategies, Inc. Charlottesville, VA Speaker Disclosure Requirements 1. Do not dispense, prescribe, refer or recommend MMJ 2. Have no

More information

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial

More information

Medical Cannabis MATT WEBSTER DO, MS

Medical Cannabis MATT WEBSTER DO, MS Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use

More information

Medical Marijuana. Gina C. Guzman, MD, DBIM, FALU, FLMI. Munich Re US (Life) 17 Nov 2016

Medical Marijuana. Gina C. Guzman, MD, DBIM, FALU, FLMI. Munich Re US (Life) 17 Nov 2016 Medical Marijuana Gina C. Guzman, MD, DBIM, FALU, FLMI Vice President & Chief Medical Director ACSW/SEAC Annual Meeting Munich Re US (Life) 17 Nov 2016 Learning Objectives 1. Provide an introduction to

More information

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator Medical Cannabis Program Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator Disclaimer The following information is based upon research of current studies. The Department of Health

More information

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into

More information

Arizona Hospice and Palliative Care Organization May 13, Medical Marijuana Impact on EOL Care

Arizona Hospice and Palliative Care Organization May 13, Medical Marijuana Impact on EOL Care Arizona Hospice and Palliative Care Organization May 13, 2011 Medical Marijuana Impact on EOL Care Objectives Know at least 5 potential medical conditions in which medical marijuana is used Identify, describe

More information

Use of Cannabinoids in Medical Practice

Use of Cannabinoids in Medical Practice Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced

More information

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy The Effects known & unknown of Marijuana in Older Adults Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy Learning Objectives 1. Review various dosing strategies for medical

More information

Be it enacted by the People of the State of Illinois,

Be it enacted by the People of the State of Illinois, SB Enrolled LRB0 0 RPM 0 b AN ACT concerning public health. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section. The Compassionate Use of Medical Cannabis

More information

Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital

Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital Disclosures No relevant financial or relationship disclosures

More information

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance

More information

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University sgkinsey@mail.wvu.edu Any opinions expressed are my own and do not reflect any official position of WVU beanpot.co

More information

Federal Law: Marijuana

Federal Law: Marijuana Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not

More information

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility. Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound

More information

Medical vs Recreational Use of Cannabis. 11 th December 2017

Medical vs Recreational Use of Cannabis. 11 th December 2017 1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.

More information

The State of Cannabis in Oregon

The State of Cannabis in Oregon The State of Cannabis in Oregon February 13, 2017 1 Status of legalization of cannabis in US Recreational Marijuana States (8 + D.C.): Colorado, Washington, Oregon, Alaska, D.C., California, Nevada, Massachusetts,

More information

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace Smoke and Mirrors: Navigating Medical Marijuana in the Workplace Douglas P. Currier Elizabeth Connellan Smith dcurrier@verrilldana.com esmith@verrilldana.com (207) 253-4450 (207) 253-4460 Some Statistics

More information

Marijuana in the Workplace: The 411 on 420

Marijuana in the Workplace: The 411 on 420 Marijuana in the Workplace: The 411 on 420 Richard Moon rmoon@verrilldana.com Tawny Alvarez talvarez@verrilldana.com Outline Super-brief history of legal cannabis Federal position as to marijuana State

More information

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

MEDICAL MARIJUANA: WHAT S THE EVIDENCE? MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y

More information

Medical Marijuana in the Workforce. What This Is...And What It Isn t

Medical Marijuana in the Workforce. What This Is...And What It Isn t Medical Marijuana in the Workforce Recommendations for the Occupational Physician Robert S. Goldsmith, M.D., M.P.H. June, 2014 What This Is...And What It Isn t IS: Historical context Legal and social context

More information

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)

More information

Susan Audino, PhD S.A. Audino & Associates, LLC

Susan Audino, PhD S.A. Audino & Associates, LLC Cachexia, Cancer, Chronic Pain, Epilepsy, Glaucoma, HIV, AIDS, Multiple Sclerosis, Nausea, ALS, Crohn s, Hepatitis C, Anorexia, Arthritis, Migraine, Parkinson s, Damage to the Nervous Tissue of the Spinal

More information

Department of Public Safety

Department of Public Safety Presented by: Lindsey Wells, Marijuana Program Administrator Department of Public Safety Vermont Marijuana Registry March 6, 2015 Vermont Law School South Royalton, VT Information Marijuana Registry Staff

More information

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid

More information

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology 2 Pamela C. Cartright, MAE, RT (R)(T) Assistant Professor and Program Director Radiation Therapy Program

More information

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymphoma Setting Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymhoma Setting Disclosure: No endorsement or promotion of marihuana

More information

MARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec

MARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec MARIJUANA in MEDICAL CARE READY or RISKY HINDI MERMELSTEIN, MD FAPM drhmermelstein @optimum.net Beth Israel Medical Center, NYC Dec 11 2015 HISTORY MARIJUANA (CANNABIS SAVITA) HAS LONG BEEN PART OF RELIGIOUS

More information

The Cannabis Legal Landscape Today. Erika Lietzan University of Missouri School of Law November 2018

The Cannabis Legal Landscape Today. Erika Lietzan University of Missouri School of Law November 2018 The Cannabis Legal Landscape Today Erika Lietzan University of Missouri School of November 2018 Federal CSA Int l State Federal FDCA Controlled Substances Act Schedule I: marihuana and tetrahydrocannabinols

More information

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce Medical marijuana and the impact of marijuana policy on children Karen M. Wilson, MD, MPH, FAAP Associate Professor of Pediatrics Section Head, Pediatric Hospital Medicine University of Colorado School

More information

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest

More information

DEPARTMENT OF COMMUNITY RESOURCES INTEROFFICE MEMORANDUM

DEPARTMENT OF COMMUNITY RESOURCES INTEROFFICE MEMORANDUM DEPARTMENT OF COMMUNITY RESOURCES INTEROFFICE MEMORANDUM TO: Board of County Commissioners VIA: Terry L. Shannon, County Administrator 1.45 FROM: Maureen T. Hoffman, Director -7"ffr DATE: May 19, 2016

More information

Medical Cannabis. Christine Yoshioka, NP

Medical Cannabis. Christine Yoshioka, NP Medical Cannabis Christine Yoshioka, NP Objectives Brief history of Cannabis in cultures Review of the Endocanabinoid system Exogenous cannabis Medical research involving cannabis and federal restrictions

More information

The Shifting Federal Regulation of Cannabis Products

The Shifting Federal Regulation of Cannabis Products The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW

More information

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State

More information

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State

More information

8/31/2016. Workplace Implications of Marijuana in the US. Goal

8/31/2016. Workplace Implications of Marijuana in the US. Goal Workplace Implications of Marijuana in the US Copyright 420 Medicated.com Goal Inform and provoke discussion about the future for patients, staff and employers in regard to this rapidly evolving and important

More information

Medical Marijuana: Current Policies and Consideration. By Michael Bertaut Healthcare Economist, BCBSLA 2019

Medical Marijuana: Current Policies and Consideration. By Michael Bertaut Healthcare Economist, BCBSLA 2019 1 Medical Marijuana: Current Policies and Consideration By Michael Bertaut Healthcare Economist, BCBSLA 2019 2 What are the States Doing? 10 States and Washington DC have legalized Marijuana for recreational

More information

Durban Poison (Pure Indica) Hindu Kush (Pure Sativa) Northern Lights (Ruderalis-Indica Hybrid) Royal Dwarf (Ruderalis-Sativa Hybrid) 11 Adapted from Figure 1. The endocannabinoid System in the Nervous

More information

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response

More information

The Highs and Lows of Medical Marijuana

The Highs and Lows of Medical Marijuana The Highs and Lows of Medical Marijuana Jill Vargo Cavalet, MHS, PA-C Marijuana use is prevalent worldwide yet remains controversial in health care. The general public often regards marijuana as a benign

More information

A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids

A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids Background paper commissioned by the EMCDDA for the report Medical use of cannabis and cannabinoids:

More information

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology

More information

History Of Medical Cannabis

History Of Medical Cannabis History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction

More information

Medical Marijuana: The Move to Schedule II

Medical Marijuana: The Move to Schedule II Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions

More information

O vercom ing Banking Obstacles for Marijuana-Related Businesses. Lori Jean Partner, Krieg DeVault LLP

O vercom ing Banking Obstacles for Marijuana-Related Businesses. Lori Jean Partner, Krieg DeVault LLP O vercom ing Banking Obstacles for Marijuana-Related Businesses Lori Jean Partner, Krieg DeVault LLP The Opportunity Legal Marijuana Sales in the U.S. Expected to reach $50B annually by 2026 CBD market

More information

Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana

Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana Carla Lomuscio, LCSW, Betsy Long, MSW and Amy Carver, PharmD Disclosures We have no financial

More information

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of

More information

Medical Marijuana Update Chris Belletieri, DO

Medical Marijuana Update Chris Belletieri, DO Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA

More information

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:

More information

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level. Introduction This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level. Definition: The term "extracts and tinctures" refers to substances that

More information

WHAT TO REMEMBER ABOUT CANNABIS HISTORY

WHAT TO REMEMBER ABOUT CANNABIS HISTORY WHAT TO REMEMBER ABOUT CANNABIS HISTORY Evidence of cannabis (CB) use goes back about 12000 yrs. Starting in Central Asia (Now India, Pakistan and Bangladesh). Hemp was used by the Greeks and Chinese in

More information

Welcome to MedWell. MedWell Health and Wellness Centers. Don t live with PAIN Live WELL MedWell. o Newspaper o Referred by.

Welcome to MedWell. MedWell Health and Wellness Centers. Don t live with PAIN Live WELL MedWell. o Newspaper o Referred by. 1 Welcome to MedWell Patient Information Date: Name: Date of Birth: / / Address: City: State: Zip Code: Home Phone: ( ) - Cell Phone: ( ) - Email: Gender: o Male o Female State Drivers License: Social

More information

Cannabinoids: access and symptom management in cancer

Cannabinoids: access and symptom management in cancer Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%

More information

Pharmacists role in Cannabis-Based Patient Care

Pharmacists role in Cannabis-Based Patient Care Pharmacist Learning Objectives Pharmacists role in Cannabis-Based Patient Care At the completion of this activity, the participant will be able to: Describe the timeline of medical cannabis programs in

More information

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD CECILIA HILLARD, PHD DEPARTMENT OF PHARMACOLOGY NEUROSCIENCE RESEARCH CENTER Disclosures Member of the Scientific Advisory Board

More information

Substitute HB 523 Outline

Substitute HB 523 Outline Substitute HB 523 Outline 1. Creates Medical Marijuana Control Commission under the auspice of the Department of Commerce 9 member commission No more than 4 members of the Commission shall be from 1 political

More information

A look at Marijuana in 2014

A look at Marijuana in 2014 A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5

More information

Medical Marijuana: Coverage Considerations for the Buckeye State. ISCEBS & CSHRM Education Session April 20, 2018

Medical Marijuana: Coverage Considerations for the Buckeye State. ISCEBS & CSHRM Education Session April 20, 2018 Medical Marijuana: Coverage Considerations for the Buckeye State ISCEBS & CSHRM Education Session April 20, 2018 DISCLAIMER Speaker has no conflicts of interest to disclose Cubic is an independent analytics

More information

50 Shades of Developing Gray Matter: Adolescents and Marijuana

50 Shades of Developing Gray Matter: Adolescents and Marijuana 50 Shades of Developing Gray Matter: Adolescents and Marijuana Ken Winters, Ph.D. Department of Psychiatry University of Minnesota winte001@umn.edu MNCAMH Webinar October 10, 2014 www.psychiatry.umn.edu/research/casar/home.html

More information

Disclosure. Medical Marijuana Updates. Nothing to disclose

Disclosure. Medical Marijuana Updates. Nothing to disclose Medical Marijuana Updates Darren Quarrie, PharmD, CPh Clinical Pharmacist Specialist, Transplant Service Orlando VA Medical Center Disclosure Nothing to disclose 1 Objectives Describe the biology of medical

More information

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists

More information

Reefer Madness version 3.0*

Reefer Madness version 3.0* Reefer Madness version 3.0* Presenter Disclosure *Original Reefer Madness: FMF 2014 by R. Dubin, Sharon Cirone and Mel Kahan Update on Health Canada s MMPR and the use of cannabis for medical conditions

More information

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the

More information

Legislation restricted all narcotics, including cannabis, as poisons required prescriptions antispasmodic

Legislation restricted all narcotics, including cannabis, as poisons required prescriptions antispasmodic Marijuana: Legal History, Neuro-Science & Toxicology LifeSavers Conference Charlotte, North Carolina March 28, 2017 Judge Mary A. Celeste (Ret.) The following presentation may not be copied in whole or

More information

Medical Use of Cannabis Products. Joachim Nadstawek

Medical Use of Cannabis Products. Joachim Nadstawek Medical Use of Cannabis Products Joachim Nadstawek Case Example 44 years restless-legs-syndrom peripheral polyneuropathy terminal renal failure status post renal transplantation sclerosis of the carotid

More information

CAPC/CPNP Coalition Face to Face Meeting October 18, 2018

CAPC/CPNP Coalition Face to Face Meeting October 18, 2018 CAPC/CPNP Coalition Face to Face Meeting October 18, 2018 Topics What is cannabis and how is it used? What does the evidence say about health effects? What about effects during pregnancy and breastfeeding?

More information

Medical Marijuana and Nursing Practice: Current Legislation, Scientific Literature Review, and Nursing Implications

Medical Marijuana and Nursing Practice: Current Legislation, Scientific Literature Review, and Nursing Implications DCM 2018 Medical Marijuana and Nursing Practice: Current Legislation, Scientific Literature Review, and Nursing Implications Kent Gowen, Maureen Cahill, Kathleen Russell, Rene Cronquist 1 NCSBN Marijuana

More information

Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014

Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014 Medical Marijuana and Student Health New England College Health Association Gordon H. Smith, Esq. October 30, 2014 Medical Marijuana Laws Alaska (1998) Arizona (1996, 2010) California (1996) Colorado (2000)

More information

EMERGENCE OF CANNABIDIOL IN MEDICINE

EMERGENCE OF CANNABIDIOL IN MEDICINE EMERGENCE OF CANNABIDIOL IN MEDICINE Sarah Katta, DO Hematology/Oncology Associate Professor of Medicine-University of Central Florida Southwest Cancer Center Orlando, Florida BACKGROUND Cannabis-There

More information

Evidence table for systematic reviews

Evidence table for systematic reviews Evidence table for systematic reviews Topic: Nausea, vomiting, appetite und weight stimulation Reviewer: CMF, RK Abbreviations: AE adverse effects; CI confidence interval; MA meta-analysis; n.r. not reported;

More information

BASIC CLINICAL CANNABINOID PROVIDER BCCP

BASIC CLINICAL CANNABINOID PROVIDER BCCP BASIC CLINICAL CANNABINOID PROVIDER BCCP Page 1 NATIONAL CANNABIS CERTIFICATION SERVICES HISTORY OF CLINICAL CANNABIS Page 2 As early as 2900BC, there are records of the healing powers of clinical cannabis.

More information

Tribes and Marijuana Affiliated Tribes of Northwest Indians February 4, 2015

Tribes and Marijuana Affiliated Tribes of Northwest Indians February 4, 2015 Tribes and Marijuana Affiliated Tribes of Northwest Indians February 4, 2015 Speakers Lael Echo-Hawk, Attorney, Garvey Schubert Chair, Indian Law Group http://www.gsblaw.com/professionals/lael echo-hawk/

More information

Weeding Through the Science of Cannabis. Ryan Vandrey, PhD

Weeding Through the Science of Cannabis. Ryan Vandrey, PhD Weeding Through the Science of Cannabis Ryan Vandrey, PhD What is Cannabis? Basic Plant Information Cannabis is a genus of plants with 3 species: Cannabis Sativa Cannabis Indica Cannabis Ruderalis Plant

More information

Medical Cannabis: A Patient Primer

Medical Cannabis: A Patient Primer Medical Cannabis: A Patient Primer This primer is meant for documented patients who are using medicinal cannabis or considering using it in the future. The information provided about this medication in

More information

Health Care Association of NJ Annual Convention & Expo October 24, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health

Health Care Association of NJ Annual Convention & Expo October 24, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health Health Care Association of NJ Annual Convention & Expo October 24, 2018 Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health Eradicating the Opioid Epidemic Eradicating the Opioid

More information

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2 WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts

More information

What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1

What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1 June 2017 1 2 What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1 Mark R. Hayes, Director of Legal Services, and Lanny Richmond II, Staff Attorney Introduction In 2016, the

More information

Cannabis Use: Scope of the Issue

Cannabis Use: Scope of the Issue Three Areas of Focus How Changing Cannabis Policy Will Affect Your Practice Kevin P. Hill, MD, MHS Director, McLean Hospital Division of Alcohol and Drug Abuse Belmont, MA Assistant Professor of Psychiatry,

More information

Drug Free Schools and Community Act

Drug Free Schools and Community Act Drug Free Schools and Community Act Collin College supports the requirements of the Drug Free Schools and Communities Act. The College also endorses the Standards of the Commission of Colleges and Universities

More information

9/18/2014 NOTHING TO DISCLOSE

9/18/2014 NOTHING TO DISCLOSE Doris C. Gundersen MD Medical Director Colorado Physician Health Program Georgia Professional Health Program CME Event Macon, Georgia November 7, 2014 Doris C. Gundersen MD Medical Director Colorado Physician

More information

Chapter 23. Medicines and Drugs

Chapter 23. Medicines and Drugs Chapter 23 Medicines and Drugs Lesson 1 The Role of Medicines 1. What are medicines? Drugs that are used to prevent disease or other conditions. 2. What are drugs? Substances other than food that change

More information

420 ADVISORY MANAGEMENT

420 ADVISORY MANAGEMENT THE CANNABIS ACT: WHAT DOES IT MEAN FOR CANADIANS? 420 CLINIC, LTD. OBJECTIVES At the end of the session, you will be able to: 1) Understand the ramifications of recreational cannabis legalization 2) Understand

More information

Medicinal cannabis use among PLWH in the era of legalization

Medicinal cannabis use among PLWH in the era of legalization Medicinal cannabis use among PLWH in the era of legalization June 8, 2017 David Grelotti, MD Assistant Professor University of California, San Diego Center for Medicinal Cannabis Research Outline Overview

More information

Therapeutic Cannabis in New Hampshire. Number to text: Goals/Objectives. Survey. WMUR Granite State Poll (February 2013) 3/29/2018

Therapeutic Cannabis in New Hampshire. Number to text: Goals/Objectives. Survey. WMUR Granite State Poll (February 2013) 3/29/2018 Therapeutic Cannabis in New Hampshire Goals/Objectives Lisa Withrow, APRN, FNP-C, ACHPN Palliativity Medical Group LLC Brief History of the NH Therapeutic Cannabis Law Certification Process Therapeutic

More information

Cannabis What's Hot What's New & What All Pharmacists Ought to Know

Cannabis What's Hot What's New & What All Pharmacists Ought to Know Cannabis 2017 What's Hot What's New & What All Pharmacists Ought to Know Andrew J Smith, MDCM Staff Physician, Pain and Addiction Medicine Medical Lead, Interprofessional Pain and Addiction Recovery Clinic

More information

Medicinal Marijuana: The Canadian Journey

Medicinal Marijuana: The Canadian Journey Medicinal Marijuana: The Canadian Journey Nady el-guebaly MD Professor & Head, Addiction Division, UofC Research Director, Alberta Gambling Research Institute Chief Examiner, ISAM Certification Disclosures:

More information

MEDICAL MARIJUANA AND HEALTH CARE FACILITIES

MEDICAL MARIJUANA AND HEALTH CARE FACILITIES MISSOURI HOSPITAL ASSOCIATION MEDICAL MARIJUANA AND HEALTH CARE FACILITIES In November, Missourians voted to decriminalize medical marijuana by approving constitutional Amendment 2. The proponents of Amendment

More information